Naltrexone News and Research

RSS

Measuring the receipt of medications and behavioral health services for AUD

Heavy drinking commonly begins in adolescence and is a known risk factor for the development of alcohol use disorder (AUD). Data from adult clinical trials suggest offering evidence-based medications for AUD to younger adults could promote their engagement in treatment and improve clinical outcomes.

15 Jun 2023

Harm reduction treatment for alcohol use disorder can also reduce the use of other substances

Quitting alcohol or drugs was not a top priority for people experiencing homelessness in a harm reduction treatment study, yet participants still reduced their use of both.

14 Jun 2023

New insight from patients on what helps or hinders medication-assisted opioid use disorder treatment

Patients would be more willing to enter medication-assisted treatment for opioid use disorder if existing stigmas were reduced and more accessible payment support was readily available, a West Virginia University study finds.

6 Jun 2023

Recovery from addiction is a journey. There’s no one-and-done solution.

The atmosphere inside the Allen House is easygoing as residents circulate freely through the hallways, meet in group sessions, or gather on a large outdoor patio that features a dirt volleyball court with an oversize net.

6 Jun 2023

California’s fentanyl problem is getting worse

California has allocated more than $1 billion in recent years to combat its opioid crisis. Much of the money has been used to distribute fentanyl test strips and the overdose reversal drug naloxone, as well as deliver medical care to people who are homeless.

23 May 2023

Insomnia drug shows potential as an effective treatment for opioid use disorder

The insomnia drug suvorexant (Belsomra) might be an effective treatment for opioid use disorder, according to a preclinical study from Scripps Research.

27 Apr 2023

Intermittent fasting shows potential benefits for obesity treatment and brain-gut-microbiome health

A recent Nutrients journal study by researchers at the David Geffen School of Medicine at the University of California, Los Angeles, has discussed the effects of time-restricted eating on BGM and reviewed its promising effects in obesity treatment.

26 Mar 2023

Skin medication shows promise in treating alcohol use disorder

Researchers from Oregon Health & Science University and institutions across the country have identified a pill used to treat a common skin disease as an "incredibly promising" treatment for alcohol use disorder.

21 Feb 2023

What are the major findings of long COVID research?

Researchers explored existing literature on long coronavirus disease (COVID). They highlighted key immunological findings, similarities with other diseases, symptoms, and associated pathophysiological mechanisms, and diagnostic and therapeutic options, including COVID-19 vaccinations.

17 Jan 2023

New fentanyl vaccine could prevent deadly opioid from entering the brain

A research team led by the University of Houston has developed a vaccine targeting the dangerous synthetic opioid fentanyl that could block its ability to enter the brain, thus eliminating the drug's "high."

14 Nov 2022

AGA releases evidence-based guidelines that recommend new obesity medications and lifestyle changes

Diet and exercise fail for most adults who try to lose weight in the long-term. Today the American Gastroenterological Association (AGA) released new evidence-based guidelines strongly recommending that these patients with obesity use recently approved medications paired with lifestyle changes.

20 Oct 2022

Study highlights the urgency of removing barriers to accessing medications for opioid use disorder

The opioid overdose and death epidemic continues to worsen across the United States, but medications such as methadone, buprenorphine, and extended-release naltrexone are proven to reduce opioid overdoses by more than 50 percent.

4 Aug 2022

Lifesaving drug for opioid use disorder underutilized

Researchers at Washington University School of Medicine in St. Louis and Saint Louis University found that less than half of Americans who received treatment for opioid use disorder over a five-year period were offered a potentially lifesaving medication.

10 May 2022

Disasters can disrupt access to medications for opioid use disorder in vulnerable communities

The COVID-19 pandemic has spiked the overdose death rate from opioid use. For people who rely on medications (buprenorphine, methadone, and extended-release naltrexone) to treat opioid use disorders, the pandemic and such natural disasters as tornados, hurricanes, and wildfires can disrupt access to medications.

20 Apr 2022

$11M for North Carolina work-based rehab raises concerns

An addiction treatment facility, highly regarded by North Carolina lawmakers, sits in a residential neighborhood here and operates like a village in itself.

6 Apr 2022

In-jail buprenorphine treatment for opioid use disorder may reduce rearrest and reconviction

A study conducted in two rural Massachusetts jails found that people with opioid use disorder who were incarcerated and received a medication approved to treat opioid use disorder, known as buprenorphine, were less likely to face rearrest and reconviction after release than those who did not receive the medication.

18 Jan 2022

Naltrexone News and Research

Measuring the receipt of medications and behavioral health services for AUD

Harm reduction treatment for alcohol use disorder can also reduce the use of other substances

New insight from patients on what helps or hinders medication-assisted opioid use disorder treatment

Recovery from addiction is a journey. There’s no one-and-done solution.

California’s fentanyl problem is getting worse

Insomnia drug shows potential as an effective treatment for opioid use disorder

Intermittent fasting shows potential benefits for obesity treatment and brain-gut-microbiome health

Skin medication shows promise in treating alcohol use disorder

What are the major findings of long COVID research?

New fentanyl vaccine could prevent deadly opioid from entering the brain

AGA releases evidence-based guidelines that recommend new obesity medications and lifestyle changes

Study highlights the urgency of removing barriers to accessing medications for opioid use disorder

Lifesaving drug for opioid use disorder underutilized

Disasters can disrupt access to medications for opioid use disorder in vulnerable communities

$11M for North Carolina work-based rehab raises concerns

In-jail buprenorphine treatment for opioid use disorder may reduce rearrest and reconviction

Psychology professor secures $2.59 million NIH grant to study the brain mechanisms of addiction

Research demonstrates a clear link between nicotine withdrawal and poor eating habits

Pharmacotherapy for alcohol use disorder is underutilized in Sweden, finds study

UCLA clinical trial shows efficacy of varenicline on heavy-drinking smokers

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News